Skip to content

Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool

Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01803009
Acronym
CRC-RAT
Enrollment
63
Registered
2013-03-04
Start date
2012-11-30
Completion date
2013-10-31
Last updated
2014-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

Little is known about the impact of risk assessment tools on decision-making by patients and clinicians. In particular, even though the NCI Colorectal Cancer Risk Assessment Tool is one of the most prominent risk assessment tools available, no study has quantified its usability or impact on decision-making or uptake of screening. In this study, we will measure patients' satisfaction with the NCI CRC RAT, their perception of its usability and helpfulness, and its impact on their decision-making and behavior. In addition, we will assess the impact of adding information about their chance of having an advanced adenoma.

Interventions

BEHAVIORALPatient views NCI CRC RAT
BEHAVIORALView presentation regarding current chance of having an advanced adenoma

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 50-75 years old * No colonoscopy performed in last 10 years, sigmoidoscopy in last 5 years, or fecal occult blood testing (including FIT) in last 1 year. * Appointment with healthcare practitioner in upcoming month or within the past six months at one of five Indiana University Health primary care sites.

Exclusion criteria

* Undergoing workup for signs or symptoms consistent with colon cancer, such as weight loss, iron-deficiency anemia, change in bowel habits, or rectal bleeding. * Enrolled in Trial of a Computer-Based Presentation of Quantitative Information about Colorectal Cancer Screening; Dr. Schwartz's study that recently completed enrollment. * Diagnosis with any of the following conditions: Ulcerative colitis, Crohn disease, Familial adenomatous polyposis (FAP), Hereditary Nonpolyposis Colorectal Cancer (HNPCC), Personal history of colorectal cancer or adenomatous polyp * Inability to speak and read English

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction with NCI CRC RAT1 day19 Likert-scale questions regarding usability of and satisfaction with the questions asked by the website to assess individual risk and the information provided
Perceived risk of developing CRC1 daySix Likert-scale questions regarding the subject's perceived risk of developing CRC in next 5 years, 10 years, and lifetime, and compared to others of same age and gender.
Intent to be screened within six months6 monthsThree multiple-choice questions regarding intent to be screened in next six months in general or with colonoscopy or stool testing. (Answer options: Definitely, Probably, Probably not, and Definitely not)
Stage of readiness to screen1 dayMeasure calculated from patient's answers on 5 multiple-choice or Likert-scale questions
Preferred CRC screening test1 dayAnswer on a single multiple choice question, offering options of colonoscopy, stool test, or other.

Secondary

MeasureTime frameDescription
Uptake of CRC screening6 months after interventionPhone call follow up and check of medical record.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026